Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
NMRA
PYPD
Add up to 3 more stocks
NMRA
Neumora Therapeutics, Inc. Common Stock
-8.43%
$0.48-0.04Delayed quote: Oct 6, 2026, 2:15 PM EDT
Market Cap
$89.12M
52W Range
$0.47 - $3.65
PYPD
PolyPid Ltd.
N/A
$5.20N/ADelayed quote: Oct 6, 2026, 2:12 PM EDT
Market Cap
$99.23M
52W Range
$3.06 - $5.73
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.00 | 18.42 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -477.9% | -584.6% |
| ROA | -169.9% | -206.8% |
| ROIC | -216.1% | 13.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 4.50 | 1.35 |
| Quick Ratio | 4.50 | 1.14 |
| Debt/Equity | 0.01 | 0.29 |
| Interest Coverage | -74.92 | -48.13 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.